At the site of the Unified Distributor, a meeting was held between the Chairman of the Board of SK-Pharmaceuticals LLP, Erken Zhakatay, and representatives of the domestic pharmaceutical company Karaganda Pharmaceutical Complex (KFC LLP).
KFC LLP was represented by General Director Sergey Baron, Marketing Director Erikbek Agatanov and Market Access Director Baurzhan Koshembaev.
Today, the Karaganda pharmaceutical complex carries out technology transfer and production of 15 biotechnological medicines for the treatment of such socially significant diseases as oncology, rare diseases, hemophilia, cardiology, rheumatoid arthritis, diabetes, etc.
As Sergei Baron, General Director of KFC LLP, noted at the meeting, thanks to this, prices for vital medicines have decreased by an average of 30% compared to imported analogues.
It should be noted that the Karaganda pharmaceutical complex is the first and only manufacturer of genetically engineered medicines in Kazakhstan. The production lines of the company are equipped with modern high-tech equipment. Every year, KFC LLP launches new high-tech drugs for the treatment of serious diseases on the market.
For the Unified Distributor, supporting domestic manufacturers is one of the priority areas of activity, which is expressed in concluding long-term contracts with Kazakh pharmaceutical companies for the supply of medicines and medical devices.
It is important to emphasize that the joint cooperation of the Unified Distributor and KFC LLP is aimed at the development of the high-tech pharmaceutical industry in Kazakhstan. This measure will increase the production of domestic drugs and reduce the cost of biological medicines.
As a result of the meeting, the parties reached an agreement on further cooperation and development of the pharmaceutical industry.
